We recently compiled a list of the 12 Cheapest Stocks with Biggest Upside Potential. In this article, we are going to take a ...
On the third day, drugmakers provided updates on precision medicines for cancer and Alzheimer's, and Grail talked about the launch of a new version of the Galleri test.
(Reuters) -UnitedHealth CEO Andrew Witty said on Thursday that healthcare in the U.S. needs to be "less confusing, less ...
AbbVie and Gilead are going back to their roots and leaning on their established areas of expertise to set themselves up for ...
Hosted on MSN1d
Novel Drug Eases Disease Activity in DermatomyositisCurrent treatments for dermatomyositis include various immunosuppressants and immunosuppressive agents, including ...
In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...
2d
The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...
The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing informa ...
J&J agreed to buy Intra-Cellular Therapies in a deal worth $14.6 billion, another sign of reentry into neuroscience by large ...
In a report released on January 9, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...
The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing how diseases develop and paving the way for simple blood tests to detect ...
CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback